A kind of vaccine composition and its preparation method and application
A vaccine composition and antigen technology, applied in the field of vaccine compositions, can solve the problems of the quality decline of the preventive effect, stress and safety problems, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0037] The preparation of embodiment 1, SIV, Mhp, APP antigen
[0038] 1. The source of bacteria (virus) strains
[0039] The SIV H1N1ZJS strain was isolated and preserved in our laboratory, the preservation number is CCTCC NO: V201233, and the preservation date is September 11, 2012.
[0040] Mhp HN0613 strain, isolated and preserved in our laboratory, the preservation number is CCTCC NO: M2012230, and the preservation date is June 13, 2012.
[0041] APP1 type LC strain, isolated and preserved in our laboratory, the preservation number is CCTCC NO: M2011458, and the preservation date is December 9, 2011.
[0042] 2. Preparation and inspection of vaccine semi-finished products
[0043] 2.1 Preparation of seeds for production
[0044] 2.1.1 Swine influenza virus
[0045] The SIV H1N1ZJS strain was inoculated into SPF chicken embryos for subculture, and the allantoic fluid was harvested as the virus fluid. The first generation was F1 and then passed to F3. The allantoic flui...
Embodiment 2
[0083] Example 2. Preparation of vaccine composition
[0084] 1 Preparation of preservatives
[0085] 1% (w / v) thimerosal (Sinopharm Chemical Reagent Co., Ltd. 20120106) aqueous solution
[0086] 2 preparation of diluent
[0087] Sterile PBS (0.01M, pH=0.02) buffer solution: dissolve 8g sodium chloride, 0.25g potassium chloride, 3.63g disodium hydrogen phosphate, 0.24g potassium dihydrogen phosphate in 900ml purified water, then dilute to 1L, autoclave at 121°C for 30 minutes for later use.
[0088] 3 preparation of adjuvants
[0089] Gel01 (French SEPPIC company 20120401), autoclaved at 121°C for 30 minutes for later use.
[0090] 4 with seedlings
[0091] Get the concentrated inactivated antigen of Mhp, SS2, SESZ prepared in Example 1, make mixed antigen solution or directly make antigen solution according to the final antigen content in combined vaccine and single vaccine, then antigen solution and Gel01 adjuvant by 90: 10 (v / v) mixed, supplemented to the required vol...
Embodiment 3
[0121] Example 3. This study is to evaluate the promoting effect of mixed infection of SIV, Mhp and APP on the pathogenesis of APP, so as to prove the synergistic effect of mixed infection of the three.
[0122] 1 Material:
[0123] Animals: 60-70 days old, pigs with negative serum antibodies to SIV, Mhp and APP
[0124] Attacking strains: SIV H1N1ZJS strain, Mhp CVCC354 strain (purchased from China Veterinary Drug Administration), APP type 1 LC strain
[0125] 2 methods:
[0126] Fifty piglets aged 60-70 days were selected and randomly divided into 10 groups with 5 pigs in each group. Different doses of APP1 type LC strains were used to challenge pigs in groups 1 to 3, and the incidence was counted after 14 days of observation; the attacking doses of SIV H1N1ZJS strain and different doses of APP type 1 LC strains were used to attack pigs in groups 4 and 5, and observations were made for 14 days. Incidence situation: Use the CVCC354 strain of the pathogenic dose and differe...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com